Bill Gross started Idealab in 1996 to create and operate pioneering technology companies. The structure of Idealab has allowed us to test many ideas at once and turn the best of them into companies, attracting the human and financial capital necessary to bring them to market.
Many of these companies were among the first to introduce new business ideas to the market. CitySearch, now a part of IAC, established the category of local online community directories. eToys demonstrated the tremendous potential for online consumer retail and became one of the most recognized brands during the early days of e-commerce. Overture Services, which began life as GoTo.com, was the first company to introduce the concept of paid search — the business model that powers the multibillion-dollar online search market.
Idealab continues to explore a range of technology frontiers. New models for improving the search experience are at the core of several companies currently growing inside of Idealab. Moving beyond the Internet, we have spawned companies with breakthrough technologies in robotics, renewable energy and automotive design and production among others. Idealab also continues to partner with leading venture capital firms and other strategic investors to provide the resources to maximize the potential of these companies.
In addition to capital, Idealab provides a full range of resources to infuse start-ups with the support they need to rapidly introduce innovative products and services. Resources include office space and the accompanying office services, development and technology, product and graphic design, marketing, financial advice, human resources, competitive research, legal, accounting and business development support and services. In addition, Idealab provides advice on strategy, branding and corporate structure.
In 2022, TECHLAB was acquired by SSI Diagnostica Group. Today, TECHLAB functions as a brand under SSI Diagnostica Group.
About SSI Diagnostica Group: SSI Diagnostica Group is a global in vitro diagnostics (IVD) company, specializing in infectious disease diagnostics. We employ staff and operate offices in Denmark, the United States, and China, with a total of eleven sites across three different continents. Each year, we deliver diagnostic solutions in more than 130 countries and manufacture more than 60 million diagnostic tests – helping people receive the right diagnosis and, ultimately, the right treatment as quickly as possible. Operating as one company today, SSI Diagnostica Group is historically the result of a series of acquisitions: SSI Diagnostica (2016), CTK Biotech (2020), Beijing Genesee Biotech (2020), Techlab (2022), Gulf Coast Scientific (2025), and InDevR (2026). Each brand has brought unique expertise and experience to the group, and as a combined company we offer more than 200 years of combined scientific expertise. SSID Group’s mission is to empower healthcare professionals to prevent, monitor, and diagnose infectious diseases – enabling better treatment outcomes for patients worldwide. SSI Diagnostica group has four disease focus areas: Gastric, Respiratory, Bloodborne, and general microbiology.
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.